MedPath

Royal Brompton & Harefield NHS Foundation Trust

Royal Brompton & Harefield NHS Foundation Trust logo
🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.rbht.nhs.uk

Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis

Completed
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
Other: 4 metre gait speed
First Posted Date
2015-08-21
Last Posted Date
2017-11-09
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
120
Registration Number
NCT02530736
Locations
🇬🇧

Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom

Prevalence of Pompe's Disease in Respiratory Clinics

Conditions
Pompe's Disease
First Posted Date
2015-08-18
Last Posted Date
2015-08-18
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
400
Registration Number
NCT02527239

Electronic Hand Hygiene Monitoring and ICU Infection Rates

Completed
Conditions
Cross Infection
Interventions
Other: Weekly poster of unit performance
Other: Daily email of personal feedback
Other: Active reminder from badge
First Posted Date
2015-07-30
Last Posted Date
2015-07-30
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
1065
Registration Number
NCT02511925
Locations
🇬🇧

Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis

Completed
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
Other: 4MGS
First Posted Date
2015-05-15
Last Posted Date
2015-10-27
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
46
Registration Number
NCT02445157
Locations
🇬🇧

Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom

Intrinsic PEEP and Laryngeal Aperture in COPD

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Procedure: Oesophageal balloon to measure intra-thoracic pressure
Procedure: Fibre-optic laryngoscopy
Other: standard lung function tests
Procedure: face mask CPAP
Procedure: variation of mouth pressure with CPAP
Other: facemask pneumotachograph
First Posted Date
2015-05-07
Last Posted Date
2017-06-07
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
30
Registration Number
NCT02437630
Locations
🇬🇧

michael apps MD, London, United Kingdom

The Predictive Ability of 4MGS in IPF

Completed
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
Other: 4MGS
First Posted Date
2015-05-06
Last Posted Date
2017-11-09
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
132
Registration Number
NCT02436278
Locations
🇬🇧

Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom

A Pilot Study of Transcoronary Myocardial Cooling

Not Applicable
Completed
Conditions
Acute Myocardial Infarction
Interventions
Other: Cohort A - Room temperature coronary perfusate
Other: Cohort B - Cooled coronary perfusate
First Posted Date
2014-12-09
Last Posted Date
2015-07-28
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
10
Registration Number
NCT02312336
Locations
🇬🇧

Royal Brompton and Harefield NHS Foundation Trust, Uxbridge, Middlesex, United Kingdom

Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)

Phase 4
Completed
Conditions
Lung; Disease, Fibroid (Chronic)
Interventions
First Posted Date
2014-11-07
Last Posted Date
2018-06-26
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
70
Registration Number
NCT02286063
Locations
🇬🇧

Royal Brompton Hospital, London, United Kingdom

A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics

Terminated
Conditions
Asthma
First Posted Date
2014-10-21
Last Posted Date
2015-10-28
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
5
Registration Number
NCT02270827
Locations
🇬🇧

Royal Brompton Hospital, London, United Kingdom

Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

Phase 4
Conditions
Venous Thrombosis
Insulin Resistance
Interventions
Drug: Femoston Conti
Drug: EVOREL® CONTI
First Posted Date
2014-10-15
Last Posted Date
2014-10-15
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Target Recruit Count
60
Registration Number
NCT02264743
Locations
🇬🇧

Chelsea and Westminster NHS Foundation Trust, London, United Kingdom

🇬🇧

Royal Brompton and Harefield NHS Trust, London, United Kingdom

🇬🇧

Imperial College Healthcare NHS Trust, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath